Drassinower D, Vink J, Pessel C, Vani K, Brubaker S G, Zork N, Ananth C V
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA.
Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USA.
Ultrasound Obstet Gynecol. 2015 Dec;46(6):718-23. doi: 10.1002/uog.14810.
Although cerclage has been shown to reduce the risk of recurrent preterm birth in a high-risk patient population, the mechanism by which this occurs is not well understood. Our objective was to evaluate whether cerclage affects the rate of cervical shortening taking into account exposure to 17-hydroxyprogesterone and vaginal progesterone.
This was a retrospective cohort study of women who had serial cervical length measurements due to a history of spontaneous preterm delivery. Demographic data, obstetric history, progesterone administration, delivery information and serial cervical length measurements were collected. The rate of cervical shortening was compared in women with and without cerclage. Subgroup analyses were performed to compare rates of cervical shortening by indication for cerclage (history indicated vs ultrasound indicated) and outcome in the current pregnancy (cerclage vs no cerclage among those who delivered preterm).
A total of 414 women were included of whom 32.4% (n = 134) had a cerclage. There was no difference in the rate of cervical shortening between the cerclage (0.8 mm/week) and no-cerclage (1.0 mm/week, P = 0.43) groups. The rates of cervical shortening among history-indicated and ultrasound-indicated cerclage groups were similar (0.9 vs 1.3 mm/week, respectively, P = 0.2). Among patients with a preterm delivery in the index pregnancy, the rates of cervical shortening among those with (1.31 mm/week) and without (1.28 mm/week, P = 0.78) cerclage were also similar.
Cervical shortening among women with cerclage occurs at a similar rate to that among women without a cerclage, regardless of indication for cerclage or pregnancy outcome.
尽管宫颈环扎术已被证明可降低高危人群复发性早产的风险,但其发生机制尚不清楚。我们的目的是评估宫颈环扎术是否会影响宫颈缩短率,同时考虑17-羟孕酮和阴道孕酮的暴露情况。
这是一项对因自发性早产史而进行系列宫颈长度测量的女性进行的回顾性队列研究。收集了人口统计学数据、产科病史、孕酮给药情况、分娩信息和系列宫颈长度测量数据。比较了接受和未接受宫颈环扎术的女性的宫颈缩短率。进行亚组分析以比较根据宫颈环扎术指征(病史提示与超声提示)的宫颈缩短率以及当前妊娠结局(早产者中接受宫颈环扎术与未接受宫颈环扎术者)。
共纳入414名女性,其中32.4%(n = 134)接受了宫颈环扎术。宫颈环扎术组(0.8毫米/周)和未环扎术组(1.0毫米/周,P = 0.43)的宫颈缩短率没有差异。病史提示和超声提示的宫颈环扎术组的宫颈缩短率相似(分别为0.9对1.3毫米/周,P = 0.2)。在本次妊娠早产的患者中,接受(1.31毫米/周)和未接受(1.28毫米/周,P = 0.78)宫颈环扎术者的宫颈缩短率也相似。
无论宫颈环扎术的指征或妊娠结局如何,接受宫颈环扎术的女性宫颈缩短率与未接受宫颈环扎术的女性相似。